Compare BCRX & GLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCRX | GLP |
|---|---|---|
| Founded | 1986 | 2005 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | N/A | N/A |
| Metric | BCRX | GLP |
|---|---|---|
| Price | $7.24 | $48.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 1 |
| Target Price | $20.82 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 4.2M | 46.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.37% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $40.21 | $22.70 |
| Revenue Next Year | $6.13 | $42.12 |
| P/E Ratio | ★ N/A | $22.94 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.00 | $39.58 |
| 52 Week High | $11.31 | $60.00 |
| Indicator | BCRX | GLP |
|---|---|---|
| Relative Strength Index (RSI) | 60.17 | 60.75 |
| Support Level | $6.26 | $47.44 |
| Resistance Level | $6.91 | $49.16 |
| Average True Range (ATR) | 0.27 | 1.22 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 97.13 | 68.09 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.